Scinovex
article Open Access

A cross sectional survey to assess the attitude and willingness to receive COVID-19 vaccination among the people of community at surendranagar district, Gujarat

International Journal of Advanced Psychiatric Nursing · 2021 · Vol. 3(2) · pp. 99–104
Gunjan BhavsarSachin SharmaSaravadiya NiraliParmar ParulDabhi NehalPatel NikhilVaghela ManaliP. RahulBadi MasudBaghela RashmiKhant Pinki

Abstract

Background and Objectives: COVID-19 is an infectious disease caused by a newly discovered corona virus. Vaccinations have been considered the best method to control rapidly spreading infectious diseases. To assess the attitude and willingness to receive COVID-19 vaccination among people of community of surendranagar, Gujarat.Method: A cross sectional survey was conducted involving the 500 people of community at Surendranagar district. Likert scale questionnaire were used to assess attitude and willingness to receive COVID-19 vaccination.Result: The result shows 0.80% people having poor scoring, 35.60% people having average score were the 57.60% people having well and 6.00% people shows excellent scoring to receive COVID-19 vaccination.Interpretation and Conclusion: We conclude that the younger people of community are more interested to receive COVID-19 vaccination than the other age group. Education is the most affective variable towards the community people.

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyVaccinationCross-sectional studyLikert scaleCoronavirus disease 2019 (COVID-19)MedicineEnvironmental healthFamily medicineInfectious disease (medical specialty)DiseasePsychology
Citations
0
FWCI
0.00
field-weighted impact
References
11
Percentile
13%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

A cross sectional survey to assess the attitude and willingness to receive COVID-19 vaccination among the people of community at surendranagar district, Gujarat · Scinovex